Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 3
2003 3
2004 2
2005 2
2006 3
2007 1
2008 1
2009 3
2010 2
2012 2
2014 1
2015 1
2016 1
2017 5
2018 3
2019 1
2020 3
2021 3
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Src: coordinating metabolism in cancer.
Pelaz SG, Tabernero A. Pelaz SG, et al. Among authors: tabernero a. Oncogene. 2022 Nov;41(45):4917-4928. doi: 10.1038/s41388-022-02487-4. Epub 2022 Oct 10. Oncogene. 2022. PMID: 36217026 Free PMC article. Review.
An update on minding the gap in cancer.
Mesnil M, Aasen T, Boucher J, Chépied A, Cronier L, Defamie N, Kameritsch P, Laird DW, Lampe PD, Lathia JD, Leithe E, Mehta PP, Monvoisin A, Pogoda K, Sin WC, Tabernero A, Yamasaki H, Yeh ES, Dagli MLZ, Naus CC. Mesnil M, et al. Among authors: tabernero a. Biochim Biophys Acta Biomembr. 2018 Jan;1860(1):237-243. doi: 10.1016/j.bbamem.2017.06.015. Epub 2017 Jun 24. Biochim Biophys Acta Biomembr. 2018. PMID: 28655619 Free article. Review.
Connexins in cancer: bridging the gap to the clinic.
Aasen T, Leithe E, Graham SV, Kameritsch P, Mayán MD, Mesnil M, Pogoda K, Tabernero A. Aasen T, et al. Among authors: tabernero a. Oncogene. 2019 Jun;38(23):4429-4451. doi: 10.1038/s41388-019-0741-6. Epub 2019 Feb 27. Oncogene. 2019. PMID: 30814684 Free PMC article. Review.
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models.
Álvarez-Vázquez A, San-Segundo L, Cerveró-García P, Flores-Hernández R, Ollauri-Ibáñez C, Segura-Collar B, Hubert CG, Morrison G, Pollard SM, Lathia JD, Sánchez-Gómez P, Tabernero A. Álvarez-Vázquez A, et al. Among authors: tabernero a. Neuro Oncol. 2024 Mar 20:noae060. doi: 10.1093/neuonc/noae060. Online ahead of print. Neuro Oncol. 2024. PMID: 38507464
Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo.
Jaraíz-Rodríguez M, Talaverón R, García-Vicente L, Pelaz SG, Domínguez-Prieto M, Álvarez-Vázquez A, Flores-Hernández R, Sin WC, Bechberger J, Medina JM, Naus CC, Tabernero A. Jaraíz-Rodríguez M, et al. Among authors: tabernero a. Neuro Oncol. 2020 Apr 15;22(4):493-504. doi: 10.1093/neuonc/noz243. Neuro Oncol. 2020. PMID: 31883012 Free PMC article.
42 results